Skip to content

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07007013
Enrollment
28
Registered
2025-06-05
Start date
2025-09-01
Completion date
2026-05-01
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medically Unexplained Symptoms

Keywords

Medically unexplained symptoms

Brief summary

This study aims to study the effectiveness of the intervention for medically unexplained symptoms(MUS) in terms of changes in emotional well-being before and after the intervention (humor therapy)

Interventions

The intervention consists of a cycle of 8 group sessions (one per week) led by trained professionals specialized in humor ('clown doctors'). Each session will last approximately 90 to 120 minutes

Sponsors

Consorci Sanitari de l'Alt Penedès i Garraf
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants may be included in the trial if they meet all of the following inclusion criteria: * Men and women over 18 years of age. * Diagnosed with the condition under study (see Section 2: Definitions). * Expected to undergo follow-up for their condition at the study center. * Ability to participate in the required assessments. * Legal capacity to provide informed consent. * Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Exclusion criteria

* Participants will be excluded if they meet any of the following

Design outcomes

Primary

MeasureTime frameDescription
emotional well-beingFrom baseline to 6 months after ending the interventionEmotional well-being will be measured before-after intervention through the Warwick-Edinburgh Mental Well-being Scale (WEMWBS). Range scale: 14-70. Higher scores indicate greater well-being.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026